Table 5.
Response by tumor subtypes and treatment line
| Characteristics | Partial response N (%) |
P |
|---|---|---|
| Triple negative | ||
| Yes | 8 (30.7) | n.s. |
| Not | 19 (21.8) | |
| ER/PgR status | ||
| ER and/or PgR positive 88 | 18 (20.5) | n.s. |
| ER and/or PgR negative 30 | 9 (30) | |
| HER2 | ||
| Overexpressed/amplified | 4 (33.3) | n.s. |
| Not overexpressed/amplified | 17 (18.2) | |
| Dominant disease site | ||
| Visceral | 22 (27.1) | n.s. |
| Non visceral | 5 (15.6) | |
| Number of metastatic disease | ||
| 1 | 3 (16.7) | n.s. |
| ≥2 | 24 (25.3) | |
| Number of prior chemotherapy for advanced disease | ||
| 2 | 8 (30.7) | n.s. |
| ≥3 | 19 (21.8) |